MedPath
NMPA Approval

Ixekizumab Injection

国药准字SJ20190034

September 10, 2024

S20190034

Drug Information

依奇珠单抗注射液

拓咨

注射剂

80mg/mL(自动注射器)

生物制品

September 10, 2024

May 8, 2029

Company Information

Applicant Company

Lilly Corporate Center, Indianapolis, IN 46285 United States of America

Manufacturing Company

Lilly Corporate Center, Indianapolis, IN 46285 United States of America

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.